These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8347442)

  • 21. Potassium channel openers: clinical applications in ischemic heart disease--overview of clinical efficacy of nicorandil.
    Knight C; Purcell H; Fox K
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():229-36. PubMed ID: 7647027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
    Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H
    Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current angina pectoris drugs].
    Gerbaux A
    Therapeutique; 1972 Feb; 48(2):165-8. PubMed ID: 4403142
    [No Abstract]   [Full Text] [Related]  

  • 24. Potassium channel openers in myocardial ischaemia: therapeutic potential of nicorandil.
    Gomma AH; Purcell HJ; Fox KM
    Drugs; 2001; 61(12):1705-10. PubMed ID: 11693460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute haemodynamic effects of nicorandil in patients with chronic severe regurgitant valvular lesions.
    Yadav R; Bhargava B; Aggarwal R; Narang R; Chopra A; Sapra R; Manchanda SC
    Indian Heart J; 1998; 50(2):173-8. PubMed ID: 9622984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolving Issues in the Treatment of Ischaemic Heart Disease: The Potassium Channel Openers. Symposium proceedings. Barcelona, Spain, 2 September 1992.
    Eur Heart J; 1993 Jul; 14 Suppl B():1-52. PubMed ID: 8103740
    [No Abstract]   [Full Text] [Related]  

  • 28. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ; Richardson PJ
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of administration of nicorandil or bimakalim prior to and during ischemia or reperfusion on survival rate, ischemia/reperfusion-induced arrhythmias and infarct size in anesthetized rabbits.
    Das B; Sarkar C; Karanth KS
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):383-96. PubMed ID: 11692221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter comparison of nicorandil and diltiazem on serum lipid, apolipoprotein, and lipoprotein levels in patients with ischemic heart disease.
    Sasaki J; Saeki Y; Kawasaki K; Umeno M; Ikeda K; Handa K; Arakawa K
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):471-4. PubMed ID: 1450091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris.
    Kishida H; Murao S
    Clin Pharmacol Ther; 1987 Aug; 42(2):166-74. PubMed ID: 2955996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of nicorandil in the treatment of myocardial ischaemia.
    Falase B; Easaw J; Youhana A
    Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotropic and coronary vasodilatory actions of the K-adenosine triphosphate channel modulator nicorandil in human tissue.
    Müller-Ehmsen J; Brixius K; Hoischen S; Schwinger RH
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1220-8. PubMed ID: 8968344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prophylactic effect of nicorandil on perioperative coronary spasm].
    Hirose Y; Gamo M; Hirose M; Harigae M; Fujiwara C
    Masui; 1998 Jun; 47(6):734-7. PubMed ID: 9691595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of nicorandil on coronary spasm.
    Aizawa T; Ogasawara K; Nakamura F; Hirosaka A; Sakuma T; Nagashima K; Kato K
    Am J Cardiol; 1989 Jun; 63(21):75J-79J. PubMed ID: 2525331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of nicorandil, a potassium agonist, on the human umbilical artery. Role of the vascular endothelium].
    Tiritilli A; Levy P; Haïat R
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1095-9. PubMed ID: 8572852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicorandil, a new vasodilator drug, in patients with essential hypertension.
    Leonetti G; Fruscio M; Gradnik R; Chianca R; Bolla GB; Prandi P; Zanchetti A
    J Hypertens Suppl; 1989 Dec; 7(6):S292-3. PubMed ID: 2534416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery.
    Kaneko T; Saito Y; Hikawa Y; Yasuda K; Makita K
    Br J Anaesth; 2001 Mar; 86(3):332-7. PubMed ID: 11573520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicorandil attenuates myocardial acidosis during coronary occlusion in dogs.
    Abiko Y; Nishimura T; Sakai K
    Br J Pharmacol; 1984 Feb; 81(2):409-11. PubMed ID: 6231074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perianal actinomycosis: a case study of this rare infection associated with nicorandil usage.
    Ablett DJ; Wylie JR; Berlansky MS
    Scott Med J; 2012 Feb; 57(1):60. PubMed ID: 22408221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.